Theratechnologies Inc.

NASDAQ: THTX · Real-Time Price · USD
3.24
0.02 (0.62%)
At close: Aug 15, 2025, 3:44 PM

Theratechnologies Cash Flow Statement

Financials in USD. Fiscal year is December - November.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Nov 30, 2024 Nov 30, 2023 Nov 30, 2022 Nov 30, 2021
Net Income
-8.31M -23.96M -47.24M -31.73M
Depreciation & Amortization
2.76M 3.31M 12.47M 8.75M
Stock-Based Compensation
3.55M 2.21M 3.87M 1.93M
Other Working Capital
-3.89M 1.92M 5.7M -2.97M
Other Non-Cash Items
8.88M 4.2M 2.74M 5.68M
Deferred Income Tax
517K 421K 443K 648K
Change in Working Capital
-5.02M 8.13M 13.02M 242K
Operating Cash Flow
2.38M -5.68M -14.69M -14.48M
Capital Expenditures
-1.5M -1.82M -985K -166K
Cash Acquisitions
n/a n/a -9.67M 39K
Purchase of Investments
-436K n/a -239K -12.76M
Sales Maturities Of Investments
2.82M 3.03M 9.91M 640K
Other Investing Acitivies
59K -1.6M 9.67M -211K
Investing Cash Flow
942K 1.11M 8.68M -12.45M
Debt Repayment
-16.09M -7.9M 10.65M -635K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-5.4M -2.48M -3.95M -7.5M
Financial Cash Flow
-21.49M 14.78M 9.66M 34.56M
Net Cash Flow
-18.2M 10.24M 3.46M 7.66M
Free Cash Flow
879K -7.5M -15.68M -14.64M